Dentsply Sirona Appoints Janet Vergis to Board

9/29/19

By Sabrina Berndt, NC Biz News

Janet Vergis

Dentsply Sirona, Inc. appointed Janet Vergis to its board, the company said in a filing with the Securities and Exchange Commission Wednesday.

Vergis has served as an executive advisor for private equity firms evaluating healthcare investment opportunities since Jan. 2013, according to the company. Previously, she served in various positions with Johnson & Johnson and its subsidiaries, including research and development and executive leadership.

She is currently a member of the board of Church & Dwight Co., Inc. and MedDay Pharmaceuticals, the company said.

“Janet brings extensive experience in the dental and healthcare industries and a proven track record of success in research and development and new product development which complements our board of directors’ skills and experiences,” said Eric Brandt, non-executive chairman of the board.

Dentsply Sirona, Inc. develops, manufactures and markets dental and oral health products and consumable medical devices.

Shares of Dentsply Sirona, Inc. were trading at $53.21 Friday afternoon, down 17 cents.

Recent Deals

Interested in advertising your deals? Contact Edwin Warfield.